Abstract:The "sphingosin" backbone of sphingolipids was so named by J. L. W. Thudichum in 1884 for its enigmatic ("Sphinx-like") properties. Although still an elusive class of lipids, research on the involvement of sphingolipids in the signal transduction pathways that mediate cell growth, differentiation, multiple cell functions, and cell death has been rapidly expanding our understanding of these compounds. In addition to the newly discovered role of ceramide as an intracellular second messenger for tumor necrosis factor-alpha, IL-1beta, and other cytokines, sphingosine, sphingosine-1-phosphate, and other sphingolipid metabolites have recently been demonstrated to modulate cellular calcium homeostasis and cell proliferation. Perturbation of sphingolipid metabolism using synthetic and naturally occurring inhibitors of key enzymes of the biosynthetic pathways is aiding the characterization of these processes; for examples, inhibition of cerebroside synthase has indicated a role for ceramide in cellular stress responses including heat shock, and inhibition of ceramide synthase (by fumonisins) has revealed the role of disruption of sphingolipid metabolism in several animal diseases. Fumonisins are currently the focus of a FDA long-term tumor study. This review summarizes recent research on (i) the role of sphingolipids as important components of the diet, (ii) the role of sphingoid base metabolites and the ceramide cycle in expression of genes regulating cell growth, differentiation, and apoptosis, (iii) the use of cerebroside synthase inhibitors as tools for understanding the role of sphingolipids as mediators of cell cycle progression, renal disease, and stress responses, and (iv) the involvement of disrupted sphingolipid metabolism in animal disease and cellular deregulation associated with exposure to inhibitors of ceramide synthase and serine palmitoyltransferase, key enzymes in de novo sphingolipid biosynthesis. These findings illustrate how an understanding of the function of sphingolipids can help solve questions in toxicology and this is undoubtedly only the beginning of this story.

Role of Sphingolipid in the Pathogenesis of Asthma

Serum Sphingolipid Profile in Asthma

Sphingolipids in lung growth and repair

Impaired Sphingolipid Synthesis in the Respiratory Tract Induces Airway Hyperreactivity

Lipid metabolism in asthma: Immune regulation and potential therapeutic target

Functions of Sphingolipids in Pathogenesis During Host–Pathogen Interactions

Sphingolipid metabolism and atherosclerosis.

Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology

Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics

Sphingolipid profiles and their relationship with inflammatory factors in asthmatic patients of different sexes

Regulation of cellular and systemic sphingolipid homeostasis

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

Potential Therapeutic Targets for Atherosclerosis in Sphingolipid Metabolism

Sphingolipids and their metabolism in physiology and disease

Drug Development in the Field of Sphinogolipid Metabolism

Sphingomyelin Biosynthesis: Its Impact on Lipid Metabolism and Atherosclerosis

S100A4 reprofiles lipid metabolism in mast cells via RAGE and PPAR-γ signaling pathway

Ceramide: a Key Signaling Molecule in a Guinea Pig Model of Allergic Asthmatic Response and Airway Inflammation

Perspective: Therapeutic Implications for Sphingolipids in Health and Disease